Evaluation of Serum Diamine Oxidase as a Diagnostic Test for Histamine Intolerance
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index; 4 of the 19 sources its claims cite were checked for support.
Abstract
Histamine intolerance (HIT) is a clinical condition caused by decreased intestinal degradation of ingested histamine, primarily due to reduced enzyme diamine oxidase (DAO) activity, leading to histamine accumulation and causing various clinical manifestations. The measurement of serum DAO is commonly used as the main diagnostic test for HIT, although its diagnostic use is still uncertain. In this retrospective study, we aimed to assess the validity of DAO determination in patients with clinically suspected HIT. We measured DAO levels in 249 patients with suspected HIT and 50 healthy adult controls without HIT-related problems. Based on five clinical criteria, we divided patients into two groups: high (all five inclusion criteria; 41 patients) and low probability of HIT (≤4 inclusion criteria; 208 patients). Patients with a “high probability of HIT” had the lowest DAO (median: 8 U/mL, IQR: 6–10) in comparison to patients with a “low probability of HIT (median: 10 U/mL, IQR: 7–16, p = 0.0006) and healthy controls (median: 18 U/mL, IQR: 14–22, p < 0.0001). The specificity and sensitivity for DAO levels < 3/< 10 U/mL (manufacturer’s set cut-off) to discriminate between patients with ‘‘high probability of HIT’’ and healthy controls were 100%/92% and 2%/71%. On the other hand, the specificity and sensitivity to discriminate between patients with ‘‘high probability of HIT’’ and ‘‘low probability of HIT’’ were 97%/61% and 2%/71%, respectively. Serum DAO determination represents an additional asset to the diagnosis of HIT based on clinical evaluation and assessment, but the diagnosis should not solely rely on DAO measurements.
Overview
CoChat Summary
## TL;DR
This retrospective study found that serum diamine oxidase (DAO) was lower in patients with a high clinical probability of histamine intolerance (HIT) than in low-probability patients and healthy controls. DAO measurement distinguished high-probability HIT from healthy controls well, but it was much less useful for separating high- from low-probability HIT, so it should be only an adjunct to clinical diagnosis.
## Key findings
- Among 249 patients with suspected HIT, 41 (16%) were classified as “high probability of HIT” and 208 (84%) as “low probability of HIT”; 50 healthy controls were also included.
- Median serum DAO was lowest in the high-probability group: 8 U/mL (IQR 6–10), versus 10 U/mL (IQR 7–16) in low-probability patients and 18 U/mL (IQR 14–22) in healthy controls.
- Using the manufacturer’s reference ranges, specificity was 100% for DAO <3 U/mL and 92% for DAO <10 U/mL; sensitivity was 2% for <3 U/mL and 71% for <10 U/mL.
- DAO was most accurate for distinguishing high-probability HIT from healthy controls: AUC 0.872 (95% CI 0.79–0.95), sensitivity 93% (95% CI 81–97%), specificity 76% (95% CI 63–86%), cut-off 13.5 U/mL.
- Discrimination between high- and low-probability HIT was limited: AUC 0.667 (95% CI 0.58–0.75), sensitivity 71% (95% CI 56–82%), specificity 61% (95% CI 54–67%), cut-off 9.5 U/mL.
## Methods
- Retrospective study at the University Clinic of Respiratory and Allergic Diseases Golnik; patients were enrolled from November 2017 to December 2020 and classified by five clinical inclusion criteria into high- or low-probability HIT groups.
- Final sample: 249 adult patients with suspected HIT and 50 age- and sex-matched healthy adult controls; 21 patients were excluded for insufficient clinical data and 30 for secondary HIT (lactose intolerance/celiac disease).
- Serum DAO was measured by quantitative ELISA (IDK DAO ELISA), and group comparisons plus ROC curve analysis were used to assess diagnostic performance.
## Limitations
- The paper states that only one DAO measurement per patient was performed, which may be limited by overlap between groups due to food intake and elimination diets.
- The paper states that it is unknown how serum DAO concentration correlates with intestinal DAO concentration, and whether the correlation is significant.
- Evident from the text: the study was retrospective and used clinical classification of HIT rather than an independent gold-standard diagnostic test, so diagnostic accuracy is judged against clinical probability groups rather than definitive confirmed HIT.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
4 Valid · 0 Not valid · 10 Not checked · 18 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Most patients with a “high probability of HIT” had DAO concentrations below 10 U/mL, similar to those reported previously [ 16 ].”
What the sources say
- Supportedcites [16] Cucca, V., Ramirez, G.A., Pignatti, P., Asperti, C., Russo, M., Della-Torre, E., Breda, D., Burastero, S.E., Lorenzo Dagna, L., and Yacoub, M.-R. (2022). Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study. Nutrients, 14. source
The Discussion (p. 1, opening paragraph) states verbatim that in their cohort of patients with suspected/confirmed HIT 'the majority of these patients had baseline DAO levels below 10 U/mL'. Results §3.1 backs this numerically: of 146 completers, 31 (21%) had DAO <3 U/mL and 60 (41%) had 3–10 U/mL, i.e. 91/146 (62%) below 10 U/mL, versus 55 (38%) with DAO >10 U/mL. The only wording the source does not use is the citing paper's own stratum label 'high probability of HIT'; the cited cohort is patients meeting HIT diagnostic criteria after allergy work-up, which is the closest analogue, so the substantive content attributed to this source is supported. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The most studied and frequently used diagnostic test for HIT is the determination of serum DAO concentration and activity.”
What the sources say
- Partly supportedcites [1] Comas-Basté, O., Sánchez-Pérez, S., Veciana-Nogués, M.T., Latorre-Moratalla, M., and Vidal-Carou, M.D.C. (2020). Histamine Intolerance: The Current State of the Art. Biomolecules, 10. sourceExperimental — accuracy not yet measured
Section 5.3 (Diagnosis of Histamine Intolerance) states that 'the most studied, and possibly also the most controversial, is the determination of plasma DAO activity', which supports the 'most studied' part of the claim. However, our copy nowhere calls it the most frequently used test — the same passage stresses that the evidence for its validity is 'neither abundant nor conclusive', that three studies found no significant relationship with clinical history and concluded it 'cannot be recommended as a diagnostic tool in routine clinical practice', and that Schnoor et al. reported high interassay variation; the section opens by noting a 'lack of validated diagnostic tools' and that no diagnostic algorithm is consensual. The claim also adds 'concentration' alongside activity, whereas the indexed text describes only the measurement of histamine-degrading (DAO) activity in blood, not DAO concentration. (LLM, conf=0.78)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Other biogenic amines present in food, such as monoamine tyramine, diamines putrescine and cadaverine, as well as polyamines spermine and spermidine, can affect DAO activity and consequently cause HIT symptoms.”
What the sources say
- Partly supportedcites [4] 2018, Allergic and intolerance reactions to wine, Allergol. Select sourceExperimental — accuracy not yet measured
The 'Histamine and biogenic amines' section of our copy names exactly the amines the claim lists (histamine, tyramine, cadaverine, putrescine, spermin, spermidine) and states that 'DAO does not only metabolize histamine but also other biogenic amines (higher affinity)', alongside the symptom list of histamine intolerance syndrome (sneezing, gastrointestinal disorders, urticaria, headache/migraine-like). However, the paper does not attribute the effect on DAO activity to those other amines themselves: the only DAO inhibitor it describes is alcohol, and the symptomatic mechanism it spells out is histamine acting on H3 receptors of the cerebral vessels; the amines it enumerates are described as formed in wine/champagne/fruit juice by malolactic fermentation rather than as food components broadly. So the causal step 'other biogenic amines affect DAO activity and consequently cause HIT symptoms' is not stated in this source — only that DAO degrades these amines (with higher affinity than histamine) and that DAO deficit/alcohol leads to histamine-related intolerance symptoms. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There is also limited knowledge about low DAO levels in healthy adults who do not present any HIT-related symptoms or signs [ 1 , 12 ].”
What the sources say
- Partly supportedcites [1] Comas-Basté, O., Sánchez-Pérez, S., Veciana-Nogués, M.T., Latorre-Moratalla, M., and Vidal-Carou, M.D.C. (2020). Histamine Intolerance: The Current State of the Art. Biomolecules, 10. sourceExperimental — accuracy not yet measured
Section 5.2 of our copy frames all existing DAO-deficiency prevalence research as pertaining to 'individuals with symptoms of histamine intolerance and/or diagnosis with certain chronic disorders', and states that 'little data is available on the prevalence of this enzymatic deficiency' (there qualified to gender) and that 'more studies are needed to assess the clinical significance of the determination of plasma DAO activity'. The only asymptomatic comparison it reports — the 44% DAO deficiency in Izquierdo et al.'s nonmigraine control group — is explicitly explained away as possibly reflecting other HIT-related symptoms (section 5.2), so the review supports sparse knowledge around DAO deficiency outside symptomatic groups but never states the claim in the specific terms used (low DAO levels in healthy adults free of any HIT symptoms or signs). The gap noted is that the paper does not address healthy, asymptomatic adults as a studied population, nor give reference data for them. (LLM, conf=0.68)
- Not checked yetcites [12] Rijavec, 2013, Serum diamine oxidase activity as a diagnostic test for histamine intolerance, Wien. Klin. Wochenschr. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Additionally, among the patients with a “low probability of HIT”, we observed a weak negative correlation between DAO concentration and the number of inclusion clinical criteria fulfilled ( p = 0.021, r = −0.160)”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
9 more claims
Create a free account to see all 32 claims and to verify the 15 references still open.
- It may state two separate claims as one. 12
- Probably not a substantial claim. 7
Citations
Cites
Histamine Intolerance: The Current State of the Art
Comas-Basté, O., Sánchez-Pérez, S., Veciana-Nogués, M. T., Latorre-Moratalla, M., & Vidal-Carou, M. D. C. (2020) · Biomolecules · doi:10.3390/biom10081181 · Cited by 246 · cited 9×
“Another alternative, which is still in the research process, is adding a microorganism that expresses the enzyme DAO to degrade accumulated biogenic amines in food [1,2,14].”
BackgroundInfluentialHistamine and gut mucosal immune regulation
Smolinska, S., Jutel, M., Crameri, R., & O'Mahony, L. (2014) · Allergy · doi:10.1111/all.12330 · Cited by 198 · cited 4×
“We can divide symptoms into six groups: gastrointestinal (diarrhoea, constipation, vomiting, and abdominal pain), cardiovascular (hypotension and arrhythmias—tachycardia), cutaneous (pruritus, urticaria, flushing), respiratory (cough, bronchospasm, rhinitis, and sinusitis), ocular (conjunctivitis), and others (headach…”
BackgroundInfluentialDiamine Oxidase: An Overview of Historical, Biochemical and Functional Aspects
Wolvekamp, M. C. J., & de Bruin, R. W. F. (1994) · Digestive Diseases · doi:10.1159/000171432 · Cited by 175 · cited 1×
“The main enzyme for the degradation of exogenous histamine is DAO, mainly expressed in epithelial cells of the small intestine, the placenta, the kidneys, and the liver [1,3–5].”
Histamine and other biogenic amines in food
Durak-Dados, A., Michalski, M. M., & Osek, J. (2020) · Journal of Veterinary Research · doi:10.2478/jvetres-2020-0029 · Cited by 166
Histamine Intolerance—The More We Know the Less We Know. A Review
Hrubiško, M., Danis, R., Huorka, M., & Wawruch, M. (2021) · Nutrients · doi:10.3390/nu13072228 · Cited by 125 · cited 3×
“The majority of patients (80%) with this condition are middle-aged [1,8,12].”
BackgroundBiogenic Amines in Plant-Origin Foods: Are they Frequently Underestimated in Low-Histamine Diets?
Sánchez-Pérez, S., Comas-Basté, O., Rabell-González, J., Veciana-Nogués, M. T., Latorre-Moratalla, M. L., & Vidal-Carou, M. C. (2018) · Foods · doi:10.3390/foods7120205 · Cited by 101 · cited 1×
“The most frequent foodstuffs rich in biogenic amines are fermented food (sauerkraut), chocolate, alcoholic drinks (red wine and champagne), cheese (aged cheese), meat (cured meat), conserved food (especially fish), vegetables (tomato, aubergine, and spinach), fruits (pineapple, grapefruit, and kiwi), and nuts [12,13].”
BackgroundSerum diamine oxidase activity in patients with histamine intolerance.
Manzotti, G., Breda, D., Di Gioacchino, M., & Burastero, S. (2016) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632015617170 · Cited by 98 · cited 2×
“Normal serum DAO concentrations are between 15 and 50 U/mL [6,7].”
BackgroundResultSerum diamine oxidase activity as a diagnostic test for histamine intolerance
Mušič, E., Korošec, P., Šilar, M., Adamič, K., Košnik, M., & Rijavec, M. (2013) · Wiener klinische Wochenschrift · doi:10.1007/s00508-013-0354-y · Cited by 84 · cited 8×
“Currently, the diagnosis is mainly achieved clinically, consisting of, at the minimum, two typical symptoms: improvement of symptoms while following a low-biogenic amine diet and treatment with antihistamines [12].”
InfluentialSelf-citationSevere Histamine Mediated Reactions to Intravenous Drugs Used in Anaesthesia
Fisher, M. M. (1975) · Anaesthesia and Intensive Care · doi:10.1177/0310057x7500300303 · Cited by 70 · cited 1×
“The severity of epithelium damage correlates with the level of diminished DAO activity [10].”
BackgroundConsidering histamine in functional gastrointestinal disorders
Schnedl, W. J., & Enko, D. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1791049 · Cited by 45 · cited 1×
“The most efficient measure to control HIT symptoms is following a low-biogenic amine diet, which is beneficial for improving symptoms and increasing serum DAO levels and activity [15].”
Background
Research works printed but not linked: 1
- Seifert, 2008, Histamine intolerance: Is the determination of diamine oxidase activity in the serum useful in routine clinical practice?, Allergologie, 31, 350
Cited by
Histamine Intolerance: Symptoms, Diagnosis, and Beyond
Jochum, C. (2024) · Nutrients · doi:10.3390/nu16081219 · Cited by 47
“One such challenge is the difficulty in establishing a clear definition due to the vague and non-specific nature of the conditions [39].”
BackgroundRentzos, G., Weisheit, A., Ekerljung, L., & van Odijk, J. (2024) · European Journal of Clinical Nutrition · doi:10.1038/s41430-024-01448-2 · Cited by 19
“Another study with a retrospective design based on both patients and a control group could link DAO levels to the probability of a diagnosis of histamine intolerance [14].”
BackgroundResultDuelo, A., Comas-Basté, O., Sánchez-Pérez, S., Veciana-Nogués, M. T., Ruiz-Casares, E., Vidal‐Carou, M. C., & Latorre‐Moratalla, M. L. (2024) · Nutrients · doi:10.3390/nu16081142 · Cited by 12
“…cut-off value for DAO deficiency in the available enzymatic In In more detail, and according to the classification proposed in other studies [2,19,23,26,27], 36 patients had DAO activity values comprised between 3 and 10 (i.e., DAO deficiency) and 7 displayed levels below 3 (highly DAO-deficient).…”
BackgroundMethodInfluentialLiu, B., Zeng, M., Kang, W., Li, S., Wang, X., Yu, H., & Wu, H. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119582 · Cited by 5
Utility of biomarkers in the postmortem diagnosis of fatal Anaphylaxis: A scoping review
Karthikeyan, B., James, R. I., Daniel, J., Senthil Kumar, R., Varughese, B. T., Manoj, D., Arakkal, A. L., & Johnson, L. R. (2025) · Legal Medicine · doi:10.1016/j.legalmed.2025.102610 · Cited by 5
Tamasi, J., & Kalabay, L. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020311 · Cited by 7
Therapeutic efficacy of fecal microbiota transplantation in severe food intolerance: a case report
Huang, Y., Huang, J., Li, Y., Xu, T., Quan, G., Xu, P., Xiao-ya, Y., Liu, Z., & Xie, W.-R. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1594022 · Cited by 4
Zhang, J., Jiang, W., Wu, P., Liu, Y., Ma, Y.-B., Shi, H.-Q., Kuang, S., Li, S.-W., Tang, L., Zhou, X., et al. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109969 · Cited by 4
Serum Immunometabolic Biomarkers Reveal Distinct Phenotypes in Chronic Urticaria
Duman, N., Müftüoğlu, C., Tahhan, B., Coşkun, T., Ece, D., Mert, U., Özkal, S., & Caner, A. (2026) · Diagnostics · doi:10.3390/diagnostics16081148 · Cited by 3
“These findings suggest that CU represents a metabolically active yet partially regulated inflammatory state, in which DAO upregulation may function as a compensatory mechanism to buffer increased histamine burden generated from chronic mast cell activation [27–29] (Figure 2).”
Dong, R., Qiu, J., Cao, J., Huang, W. L., Chen, B., Zhao, H., Sun, W., Lü, H., Loh, J., & Peng, K. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1558942 · Cited by 2
“…Institute (Nanjing, China) were used according to the methods described in other studies to determine the serum diamine oxidase (A088-2-1) activity (26) and lipopolysaccharide (H255-1-1) concentrations (27), and the intestinal trypsin (A080-2-2), lipase (A054-1-1) and amylase (C016-1-1) activities…”
Duelo, A., Sánchez-Pérez, S., Pellicer-Roca, S., Sánchez-Buxens, S., Comas-Basté, O., Latorre‐Moratalla, M. L., & Vidal‐Carou, M. C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134573 · Cited by 3
Schnedl, W. J., Michaelis, S., Enko, D., & Holasek, S. J. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.11.007 · Cited by 2
Rijavec, M., Kogovšek, Ž., Inkret, J., Kopač, P., Košnik, M., & Korošec, P. (2026) · Clinical & Experimental Allergy · doi:10.1111/cea.70227 · Cited by 2
“Notably, none of the healthy controls exceeded 50 U/mL [17].”
InfluentialSelf-citationHistamin İntoleransına Güncel Bakış
Öztekin, Y. (2024) · İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi · doi:10.38079/igusabder.1377431 · Cited by 1
Diamine Oxidase and Gastrointestinal Diseases
Żybul, P., Przybyłkowski, A. M., Wojas, O., & Samolinski, B. K. (2026) · Biomolecules · doi:10.3390/biom16081136 · Cited by 1
“…are difficult to contextualize because reference intervals are not robustly established, physiological variability related to circadian rhythms, menstrual cycle or pregnancy is substantial, and studies have reported inconsistent relationships between serum DAO and symptom burden [31,49,57,68–70].”
Gharote, H. P., Panchbhai, A. S., & Joshi, D. (2025) · BMC Oral Health · doi:10.1186/s12903-025-05772-2 · Cited by 1
“DAO supplementations in those patients have shown improvement in signs of histamine intolerance [34–36].”
Role of diamine oxidase in the management of angioedema
Donado, M. C. D., Ze, D. L., Guijo, J. M., Madera, J. J. F., & Estévez, M. D. Q. (2024) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2024.11.011
Frost, G., Lutz, C., Schwiertz, A., Huber, H., & Mißbichler, A. (2025) · Analytical Biochemistry · doi:10.1016/j.ab.2025.115819
Therapeutic management in histamine intolerance
de Sousa, I. C. C., Souza, G., Andrade, E. D. D. O., Monteiro, N. D. K. V., & Machado, R. J. D. A. (2025) · Journal of Health & Biological Sciences · doi:10.12662/2317-3076jhbs.v13i1.5746.pe5746.2025
Aguilar-Rodea, P., Mejía-Ramírez, V., Hernández-Munguía, R., Ramírez-Vargas, S., Vivar, D. T., Leyva-Hernández, J., Nacar-Gutiérrez, J. C., Morales‐Martínez, M., & Palafox-Zaldivar, A. (2025) · Biomedicines · doi:10.3390/biomedicines13092280
“Histamine intolerance (HIT) is described as an alteration in histamine homeostasis, mainly caused by decreased intestinal metabolization of exogenous histamines attributed to DAO deficiency [4,7].”
Zhu, W., Zhang, N., Wang, X., Xiong, Y., Wang, Y., & Yang, F. (2026) · Biology · doi:10.3390/biology15171556
“Intestinal DAO activity is a well-established biomarker of intestinal mucosal damage and epithelial permeability [51].”
Metadata
- Authors
- Arih, K., Đorđević, N., Košnik, M., & Rijavec, M.
- Affiliations
- University of Ljubljana (SI)
- Corresponding author
- Rijavec, Matija
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-10-02
- Volume
- 15
- Issue
- 19
- Pages
- 4246
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10574399
- OpenAlex
- W4387264754
- Cited by
- 20
- References
- 19
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 5
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository of the University of Ljubljana (University of Ljubljana) (submittedVersion, cc-by)
- Funders
- Slovenian Research and Innovation Agency (P3-0360)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- histamine intolerance, diamine oxidase, diagnostic test validity, sensitivity and specificity, histamine accumulation, clinical criteria, cut-off values
- MeSH terms
- Adult, Diagnostic Tests, Routine, Amine Oxidase (Copper-Containing), Histamine, Humans, Retrospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.